SCHEMBL23976179

SCHEMBL23976179

CN1CCC(Oc2ccnc(-c3nc4c(c(N(C)CC(=O)NC(C)(C)C)n3)CCC4)c2)C1

nearest known ligand 0.35

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SYK P43405 5/20 0.35
SLC2A1 P11166 2/20 0.34
SLC2A3 P11169 2/20 0.34
PDE10A Q9Y233 2/20 0.34
LNPEP Q9UIQ6 1/20 0.33
GAA P10253 1/20 0.33
MAPK1 P28482 1/20 0.33
RECQL P46063 1/20 0.33
ACACB O00763 5/20 0.33
MEN1 O00255 1/20 0.33
POLB P06746 1/20 0.33
KMT2A Q03164 1/20 0.33
GCK P35557 1/20 0.32
HDAC1 Q13547 1/20 0.32
HDAC8 Q9BY41 1/20 0.32
HDAC6 Q9UBN7 1/20 0.32
SPR P35270 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30118646 1.00 SYK (0.35) SYKSLC2A1SLC2A3PDE10ALNPEP
SCHEMBL23976645 1.00 SYK (0.35) SYKSLC2A1SLC2A3PDE10ALNPEP
SCHEMBL30118726 1.00 SYK (0.35) SYKSLC2A1SLC2A3PDE10ALNPEP
SCHEMBL23976471 1.00 SYK (0.35) SYKSLC2A1SLC2A3PDE10ALNPEP
SCHEMBL23976815 0.97 SYK (0.34) SYKSLC2A1SLC2A3PDE10AGAA
SCHEMBL23976129 0.97 SYK (0.34) SYKSLC2A1SLC2A3PDE10AGAA
SCHEMBL23976813 0.97 SYK (0.34) SYKSLC2A1SLC2A3PDE10AGAA
SCHEMBL25941902 0.96 SYK (0.34) SYKSLC2A1SLC2A3PDE10AGAA
SCHEMBL23976727 0.95 SYK (0.34) SYKSLC2A1SLC2A3PDE10AGAA
SCHEMBL23976780 0.92 SLC2A1 (0.35) SYKSLC2A1SLC2A3PDE10AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021222363-A1 CYCLOALKYL PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed
WO-2021222483-A1 METHODS OF USE FOR PYRIMIDINES AS FERROPORTIN INHIBITORS GLOBAL BLOOD THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed